US Patent Issued to UCB Holdings on Feb. 24 for "Inflammatory disease treatment with complement inhibitors" (French, American Inventors)

ALEXANDRIA, Va., Feb. 24 -- United States Patent no. 12,558,398, issued on Feb. 24, was assigned to UCB Holdings Inc. (Smyrna, Ga.).

"Inflammatory disease treatment with complement inhibitors" was invented by Petra Duda (Charlestown, Mass.), Ramin Farzaneh-Far (Brookline, Mass.), Alonso Ricardo (Winchester, Mass.), Camil Sayegh (Belmont, Mass.), Nanqun Zhu (Lexington, Mass.), Douangsone D. Vadysirisack (Boston), Olivier Boyer (Rouen, France) and Laurent Drouot (Blainville-Crevon, France).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure provides methods of treating inflammatory indications with complement inhibitor compounds and compositions. Included are compounds and methods of treating ...